These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6135715)

  • 21. Comparison of the effect of indoramin and prazosin on blood pressure and lipid profiles in essential hypertension.
    Overlack A; Stumpe KO
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S53-5. PubMed ID: 2423798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvement in angina pectoris with alpha adrenoceptor blockade.
    Collins P; Sheridan D
    Br Heart J; 1985 May; 53(5):488-92. PubMed ID: 2859870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [In what sense are alpha 1-receptor blockers as first choice agents in treatment of hypertension suitable?].
    Düsing R
    Internist (Berl); 1996 Sep; 37(9):941. PubMed ID: 8964692
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of pharmacokinetics and pharmacodynamics of adrenoceptor agonists and antagonists as antihypertensive agents.
    Louis WJ; McNeil JJ; Anavekar SN; Conway EL; Workman B; Howes LG; Drummer OH; Jarrott B
    J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S100-3. PubMed ID: 2455158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A study of alpha 1-adrenoceptors in rat renal cortex: comparison of [3H]-prazosin binding with the alpha 1-adrenoceptor modulating gluconeogenesis under physiological conditions.
    McPherson GA; Summers RJ
    Br J Pharmacol; 1982 Sep; 77(1):177-84. PubMed ID: 6127133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Within patient comparison of prazosin and UK-33,274. A new alpha-adrenoceptor-antagonist.
    de Leeuw PW; Ligthart JJ; Smout AJ; Birkenhäger WH
    Eur J Clin Pharmacol; 1982; 23(5):397-401. PubMed ID: 6129979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical application of adrenoceptor blockers in the treatment of hypertension].
    Mikami H; Ogihara T
    Nihon Rinsho; 1989 Sep; 47(9):2035-40. PubMed ID: 2574242
    [No Abstract]   [Full Text] [Related]  

  • 28. Indoramin.
    Lancet; 1981 Jun; 1(8232):1243-4. PubMed ID: 6112572
    [No Abstract]   [Full Text] [Related]  

  • 29. Recent developments in noradrenergic neurotransmission and its relevance to the mechanism of action of certain antihypertensive agents.
    Langer SZ; Cavero I; Massingham R
    Hypertension; 1980; 2(4):372-82. PubMed ID: 6105128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacologic and therapeutic significance of alpha-adrenoceptor subtypes.
    Langer SZ; Duval N; Massingham R
    J Cardiovasc Pharmacol; 1985; 7 Suppl 8():S1-8. PubMed ID: 2417042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Alpha blockers in the treatment of benign hyperplasia of the prostate].
    Gómez Sancha F; Fernández Arjona M; Peinado Ibarra F; Fernández Borrell A; Mínguez Martínez R; Pereira Sanz I
    Rev Clin Esp; 1997 May; 197(5):358-62. PubMed ID: 9280971
    [No Abstract]   [Full Text] [Related]  

  • 32. The alpha 1- and alpha 2-adrenoceptor selectivity of drugs with potential effects on blood pressure--a radioligand-binding study.
    Offermeier J; van Rooyen JM; Rossouw J
    S Afr Med J; 1986 Feb; 69(4):234-6. PubMed ID: 2869590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Alpha-adrenoceptor antagonist (blocker)].
    Shigetomi S
    Nihon Rinsho; 1997 Aug; 55(8):2055-60. PubMed ID: 9284423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alpha-adrenergic receptor blockade with prazosin. Consideration of hypertension, heart failure, and potential new applications.
    Colucci WS
    Ann Intern Med; 1982 Jul; 97(1):67-77. PubMed ID: 6124197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postjunctional alpha-adrenoceptors in the rabbit isolated distal saphenous artery: indirect sensitivity to prazosin of responses to noradrenaline mediated via postjunctional alpha 2-adrenoceptors.
    Dunn WR; McGrath JC; Wilson VG
    Br J Pharmacol; 1991 Jun; 103(2):1484-92. PubMed ID: 1679360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Haemodynamic effects of alpha-receptor blockade during acute administration and chronic treatment.
    Rasmussen K
    Acta Med Scand Suppl; 1982; 665():83-5. PubMed ID: 6130679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Progress in the studies of alpha1-adrenoceptor blocker for concurrent benign prostatic hyperplasia and hypertension].
    Yang MG; Zhao XK
    Zhonghua Nan Ke Xue; 2007 Sep; 13(9):830-4. PubMed ID: 17929564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Terazosin for hypertension.
    Med Lett Drugs Ther; 1987 Dec; 29(755):112-3. PubMed ID: 2891021
    [No Abstract]   [Full Text] [Related]  

  • 39. New developments in alpha-adrenergic receptor pharmacology: implications for the initial treatment of hypertension.
    Colucci WS
    Am J Cardiol; 1983 Feb; 51(4):639-43. PubMed ID: 6131604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antianginal and haemodynamic effects of alpha 1-adrenoceptor blockade.
    Sheridan DJ; Thomas P; Culling W; Collins P
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S144-50. PubMed ID: 2423788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.